This inventor holds 2 USPTO granted patents and 8 published patent applications. Top assignee: Contineum Therapeutics, Inc.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: The Innovations of Austin Chih-Yu Chen
Introduction
Austin Chih-Yu Chen is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target the muscarinic acetylcholine receptor.
Latest Patents
Austin holds a patent for "Muscarinic acetylcholine M1 receptor antagonists." This patent includes compounds that serve as antagonists of the muscarinic acetylcholine receptor M (mAChR M). The patent also details synthetic methods for creating these compounds, pharmaceutical compositions that include them, and methods for treating neurological and psychiatric disorders linked to muscarinic acetylcholine receptor dysfunction.
Career Highlights
Austin is currently employed at Contineum Therapeutics, Inc., where he continues to innovate in the field of therapeutic compounds. His work focuses on addressing critical health issues through the development of new medications.
Collaborations
Austin collaborates with notable colleagues, including Yifeng Xiong and Jeffrey Roppe, to advance research and development in their field.
Conclusion
Austin Chih-Yu Chen's contributions to pharmacology and his innovative patent work highlight his role as a key figure in the development of treatments for neurological and psychiatric disorders. His ongoing efforts at Contineum Therapeutics, Inc. continue to pave the way for future advancements in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile